drugset / Trial / NCT07563296

KALM-B: Ketamine-assisted Psychotherapy (KAP) to Lessen Morbidity After Burn Injury

NCT07563296 ↗

Phase 2 Not yet recruiting 12 enrolled Irma Fleming University of Utah · collab
NaSingle-groupOpen-labelTreatment

Summary

A study looking at the safety and tolerability of KAP (Ketamine-Assisted Psychotherapy) in the burn population.

Timeline

Start
2026-04-01
Primary completion
2027-12-01
Completion
2028-04-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.5 mg/kg Intramuscular